Hepatitis C Cure after 6 months of telaprevir-based therapy in an HIV-infected man

Clinical Infectious Diseases

Volumn 56, Issue 1, 2013, Pages 163-164

  Cachay, Edward R ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ATAZANAVIR; EMTRICITABINE; INTERLEUKIN 28B; METHAMPHETAMINE; PEGINTERFERON; RIBAVIRIN; RITONAVIR; TELAPREVIR; TENOFOVIR;

ADULT; ALLELE; CASE REPORT; CD4 LYMPHOCYTE COUNT; GENETIC POLYMORPHISM; GENOTYPE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; LETTER; MALE; MORNING DOSAGE; PRIORITY JOURNAL; RELAPSE; VIRUS LOAD;

EID: 84871202343     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis826     Document Type: Letter

References (2)

1. Malato Y, Naqvi S, Schürmann N, et al. Fate tracing of mature hepatocytes in mouse liver homeostasis and regeneration. J Clin Invest 2011; 121:4850-60.
2. Sherman KE, Flamm SL, Afdhal NH, et al. Response-guided telaprevir combination treatment for hepatitis C virus infection. N Engl J Med 2011; 365:1014-24.